Mr. Mark Davis reports
CHEMTRADE LOGISTICS INCOME FUND REPORTS SECOND QUARTER 2019 RESULTS
Chemtrade Logistics Income Fund has released its results for the three months and six months ended June 30, 2019. The financial statements and management and discussion and analysis will be available on Chemtrade's website and on SEDAR.
Chemtrade also announced that it has decided to sell its Potassium Chloride business located in Midlothian, Texas and its Vaccine Adjuvants business in Berkeley Heights, New Jersey. Although no sale has been concluded, the decision to sell requires the businesses to be reclassified as Assets Held for Sale. These businesses generated approximately US$14.0 million of Adjusted EBITDA for the twelve months ended June 30, 2019. This has also resulted in a non-cash goodwill impairment charge ("Goodwill Impairment") of the remaining specialty chemicals of US$50.0 million, in the second quarter.
2019 results include the application of IFRS 16 at January 1, 2019. In relation to leases that were previously classified as operating leases, Chemtrade now recognizes depreciation and interest expense, instead of operating lease expense. This results in an increase in EBITDA, but it does not affect Distributable Cash after maintenance capital expenditures. Also, comparative information is not restated.
The second quarter results for 2018 and the first quarter results for 2019 include, respectively, a litigation reserve ("Litigation Reserve") of $65.0 million and an increase in the reserve of $40.0 million to cover the costs of resolving the civil actions commenced against General Chemical entities related to the anti-trust matter inherited with Chemtrade's acquisition of General Chemical in 2014. The Litigation Reserve and the increase in the reserve are reflected in both EBITDA and Distributable Cash after maintenance capital expenditures for the second quarter and first six months of 2018 and for the first six months of 2019.
Revenue for the second quarter of 2019 was $396.7 million, which was $8.5 million lower than the second quarter of 2018. The primary reason for the decline was lower revenue in the Electrochemicals ("EC") segment.
Net loss for the second quarter of 2019 was $57.6 million, compared with a net loss of $50.4 million in 2018. Excluding the Goodwill Impairment in 2019 and the Litigation Reserve in 2018, net earnings were $8.0 million in 2019 compared with $14.6 million in 2018.
Adjusted EBITDA(1) for the second quarter of 2019 was $91.3 million compared with $70.5 million in the second quarter of 2018, excluding the Litigation Reserve. The increase in Adjusted EBITDA is due to better results in the Sulphur Products & Performance Chemicals ("SPPC") segment and due to the adoption of IFRS 16, which had a positive impact of $13.6 million.
Cash flows from operating activities were $51.8 million compared with $27.0 million during the second quarter of 2018. Adjusted cash flow from operating activities(1) was $58.2 million compared with adjusted cash flows used in operating activities of $19.7 million generated during the second quarter of 2018.
Distributable Cash after maintenance capital expenditures(1) for the second quarter of 2019 was $41.0 million or $0.44 per unit compared with $33.6 million or $0.36 per unit in 2018 (excluding the Litigation Reserve and financing costs of $7.4 million).
For the six months ended June 30, 2019, excluding the Litigation Reserve, Distributable Cash after maintenance capital expenditures was $83.5 million, or $0.90 per unit compared with $77.8 million, or $0.84 per unit in 2018, excluding the Litigation Reserve and financing costs. Revenue for the six months was $782.0 million (2018: $786.8 million). Adjusted EBITDA was $135.2 million (2018: $77.4 million). Adjusted cash flow from operating activities was $69.7 million (2018: $34.4 million).
Chemtrade President and Chief Executive Officer, Mark Davis, said, "Our plants performed well in the second quarter. The benefits of the initiatives we implemented last year were evident in our second quarter results, particularly in the SPPC segment. We have successfully adapted the sulphuric acid business to reflect the reduced supply of byproduct acid. These initiatives along with higher selling prices generated strong results in SPPC. In our Water Solutions and Specialty Chemicals ("WSSC") segment, water treatment contract renewals are being made at rates that more than offset increased raw material cost increases. Some of this improvement, however, was offset by weakness in certain specialty chemical products. Our EC segment continued to be affected by low caustic soda and hydrochloric acid ("HCl") prices."
In the second quarter of 2019, SPPC generated revenue of $126.4 million compared to $128.5 million in 2018. Adjusted EBITDA for the quarter was $45.3 million, which was $19.6 million higher than 2018. SPPC benefited from better operations, including adjustments in sales to reflect reduced supply of byproduct acid. Also, selling prices for merchant sulphuric acid continued to be strong and more than offset the effect of lower sales volumes. The balance includes the positive impact of IFRS 16 of $5.5 million and a $2.6 million recovery related to the settlement of a claim related to the failure of capital equipment at one of the acid manufacturing plants. There were also fewer plant turnarounds in the second quarter of 2019 compared with last year.
The WSSC segment reported second quarter revenue of $115.5 million compared with $112.4 million in 2018. Adjusted EBITDA was $20.9 million, including the positive IFRS 16 impact of $1.0 million, compared with $22.4 million generated in 2018. Selling prices for water products more than offset higher raw material costs. However, the positive impact of improved performance of water products was more than offset by lower volumes for specialty chemicals.
The EC segment reported revenue of $154.8 million for the second quarter of 2019, which was $9.6 million lower than the same period of 2018. Although volumes were higher than last year when the North Vancouver plant had an extended maintenance outage, continued weakness in selling prices for caustic soda and HCl more than offset the benefit of higher volumes. Chlorate volumes were lower due to reduced demand from pulp mills. Adjusted EBITDA for the second quarter of 2019, including the $6.7 million benefit from IFRS 16, was $5.5 million higher than the same period of 2018. Ignoring the benefit of IFRS 16 on 2019 results, Adjusted EBITDA in the second quarter of 2019 was slightly lower than 2018. Selling prices for caustic soda and HCl during the second quarter of 2019 were significantly lower than the second quarter of 2018. However, this was almost fully offset by higher volumes of caustic soda and reduced costs compared to 2018 that included the costs to repair the piping issue at the North Vancouver plant.
Corporate costs during the second quarter of 2019 were $21.3 million, including a positive IFRS 16 impact of $0.4 million, compared with $18.5 million in the second quarter of 2018, excluding the Litigation Reserve in 2018. The second quarter of 2019 includes a foreign exchange loss of $2.8 million compared to a loss of $3.8 million in 2018.
Mr. Davis said, "We were pleased with the performance of our businesses in the second quarter, and for the first half of this year. Although caustic soda prices are disappointing, the long-term outlook remains positive. We believe the sale of our two specialty chemical businesses, if concluded, will be a positive development for Chemtrade, allowing us to pay down long-term debt, strengthen our balance sheet and provide added flexibility to pursue further organic and other growth opportunities."
Despite the near-term weakness in chlor-alkali products, Chemtrade is maintaining its Adjusted EBITDA guidance for 2019, although it now believes that it will be at the lower end of the range. Further details of this, including updated assumptions are contained in Chemtrade's second quarter Management's Discussion and Analysis.
Distributions declared in the second quarter totalled $0.30 per unit, comprised of monthly Distributions of $0.10 per unit.
Chemtrade operates a diversified business providing industrial chemicals and services to customers in North America and around the world. Chemtrade is one of North America's largest suppliers of sulphuric acid, spent acid processing services, inorganic coagulants for water treatment, sodium chlorate, sodium nitrite, sodium hydrosulphite and phosphorus pentasulphide. Chemtrade is a leading regional supplier of sulphur, chlor-alkali products, liquid sulphur dioxide, potassium chloride, and zinc oxide. Additionally, Chemtrade provides industrial services such as processing by-products and waste streams.
A conference call to review the second quarter 2019 results will be webcast live on Wednesday, August 14, 2019 at 9:30 a.m. ET. To access the webcast click here.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.